We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+16.47%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.6B
AUM Growth
+$842M
Cap. Flow
-$440M
Cap. Flow %
-4.14%
Top 10 Hldgs %
16.26%
Holding
2,304
New
726
Increased
425
Reduced
494
Closed
615

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$240M
2
TMO icon
Thermo Fisher Scientific
TMO
+$151M
3
BSX icon
Boston Scientific
BSX
+$121M
4
AMZN icon
Amazon
AMZN
+$104M
5
TRU icon
TransUnion
TRU
+$81M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.87%
2 Healthcare 20.58%
3 Financials 10.9%
4 Technology 10.13%
5 Industrials 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARAV
2126
DELISTED
Aravive, Inc. Common Stock
ARAV
-6
Closed
HALL
2127
DELISTED
Hallmark Financial Services, Inc.
HALL
-1,111
Closed -$119K
SGEN
2128
DELISTED
Seagen Inc. Common Stock
SGEN
-8,071
Closed -$457K
ARCE
2129
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
-43,127
Closed -$953K
TRHC
2130
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
-32,582
Closed -$2.08M
FRGI
2131
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
-87,486
Closed -$1.36M
NUVA
2132
DELISTED
NuVasive, Inc.
NUVA
-36,566
Closed -$1.81M
ACGN
2133
DELISTED
Aceragen Inc
ACGN
-2,393
Closed -$113K
SPPI
2134
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-8,940
Closed -$78K
AJRD
2135
DELISTED
Aerojet Rocketdyne Holdings
AJRD
-1,481
Closed -$52K
RUTH
2136
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
-25,129
Closed -$571K
BLCM
2137
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$0 ﹤0.01%
+5
New +$167
AQUA
2138
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
-596,535
Closed -$5.73M
JNCE
2139
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-25,999
Closed -$88K
BSMX
2140
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
-338,059
Closed -$2.08M
MAXR
2141
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
-23,117
Closed -$276K
SJR
2142
DELISTED
Shaw Communications Inc.
SJR
-26,633
Closed -$482K
EVOP
2143
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
-9,865
Closed -$243K
STOR
2144
DELISTED
STORE Capital Corporation
STOR
-159,687
Closed -$4.52M
ZNH
2145
DELISTED
China Southern Airlines Company Limited
ZNH
-27,168
Closed -$824K
CEA
2146
DELISTED
China Eastern Airlines
CEA
-7,755
Closed -$211K
CHRA
2147
DELISTED
Charah Solutions, Inc Common Stock
CHRA
-475
Closed -$40K
CLVS
2148
DELISTED
Clovis Oncology, Inc.
CLVS
-36,184
Closed -$650K
ZEN
2149
DELISTED
ZENDESK INC
ZEN
$0 ﹤0.01%
1
-106,623
-100% -$7.83M
TEN
2150
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
-26,473
Closed -$725K

Similar funds

Marshall Wace's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace held 2,304 positions worth $10.6B, up 8.6% from $9.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace withdrew a net $440M in Q1 2019, closing 615 positions and reducing 494 holdings. Its most notable exit was Shire pic, an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Marshall Wace opened a new position in TransUnion worth $87.4M.

  • Marshall Wace's largest Q1 2019 buy was TransUnion: 1,307,679 shares worth $87.4M.
  • Marshall Wace added most to McDonald's in Q1 2019, an estimated $240M increase.
  • Marshall Wace's biggest Q1 2019 reduction was Alphabet (Google) Class A, cutting an estimated $132M.
  • Marshall Wace fully exited Shire pic in Q1 2019, selling an estimated $166M.
  • Marshall Wace's ten largest holdings make up 16% of its $10.6B portfolio in Q1 2019.
  • Marshall Wace opened 726 new positions and closed 615 in Q1 2019.
  • Marshall Wace's portfolio value rose 8.6% quarter-over-quarter to $10.6B.

Based on Marshall Wace's 13F filing for Q1 2019, filed 14 May 2019.